Hiroyuki Uetake

机构：National Hospital Organization, National Disaster Medical Center · ORCID：0000-0001-7162-6842

发表论文 447 篇 · 总被引 9298 次 · h-index 44

代表论文

Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With RAS Wild-type, Left-Sided Metastatic Colorectal Cancer (2023 · JAMA · 被引 281)
Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer (2024 · Nature Medicine · 被引 120)
Clinical significance of Bacteroides fragilis as a potential prognostic factor in colorectal cancer (2023 · Anaerobe · 被引 15)
Strategic Insight into the Combination Therapies for Metastatic Colorectal Cancer (2023 · Current Oncology · 被引 15)
Prediction of long-term recurrence-free and overall survival in early-onset colorectal cancer: the ENCORE multi-centre study (2025 · npj Precision Oncology · 被引 8)
Genomic landscape and its prognostic significance in stage III colorectal cancer: JCOG1506A1 , an ancillary of JCOG0910 (2023 · Cancer Science · 被引 8)